shutterstock_1572740566_nitpicker
nitpicker / Shutterstock.com
12 January 2021Big PharmaMuireann Bolger

Sanofi buys Kymab in boost to immunotherapy portfolio

Sanofi will buy British immunotherapy firm Kymab for up to $1.45 billion, as it seeks to expand in the rapidly growing immunotherapy field.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
28 July 2016   Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.
Africa
16 November 2016   Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.

More on this story

Big Pharma
28 July 2016   Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.
Africa
16 November 2016   Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.

More on this story

Big Pharma
28 July 2016   Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.
Africa
16 November 2016   Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.